Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The FDA’s recent approval of updated Pfizer-BioNTech and Moderna COVID-19 vaccines marks a significant step in adapting to current viral variants. Stay informed and prepare to update vaccination protocols accordingly.
Clinical Pharmacology September 29th 2023
MedTech Dive
Stay informed on the FDA’s new cybersecurity guidelines for medical devices, as they set the standard for compliance and patient data safety.
All Specialties September 28th 2023
MDLinx
Unprecedented eye drop recalls have led to significant health risks, including four fatalities. Learn more to ensure that you guide your patients towards safer, FDA-approved alternatives.
Ophthalmology September 26th 2023
Discover how Miebo, supported by phase 3 clinical trials, offers a unique approach to dry eye disease by specifically targeting tear evaporation.
Optometry September 26th 2023
Oncology News Central (ONC)
Stay informed with the FDA’s latest update on temozolomide labeling, which includes new indications and safety guidelines crucial for treating specific brain tumors.
Oncology, Medical September 19th 2023
Practical Neurology
Explore the FDA-approved Tyruko, a biosimilar to Tysabri, which has shown comparable safety and efficacy in phase 3 clinical trials for treating relapsing forms of MS.
Neurology September 6th 2023